文献速递消化系统肿瘤

II/III期结直肠癌根治术后复发风险的时间依赖模式:四项III期随机对照试验整合分析

Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4).
PubMed 文献 · Eur J Cancer · 2026-07-23

该研究整合日本临床肿瘤组四项RCT的3655例根治性切除pStage II/III结直肠癌患者个体数据,采用核平滑风险函数分析复发风险的时间动态。pStage II和III的5年RFS分别为87.9%和77.0%,复发风险峰值分别出现在术后10.0和12.8个月,且因分期、预后因素和转移部位呈现不同时间模式。

要点

  • pStage II和III结直肠癌复发风险峰值分别在术后10.0和12.8个月。
  • pStage III未接受辅助化疗者复发峰值早至3.3个月,显著早于接受化疗者的12.8个月。
  • 肝转移复发风险峰值最早(8.0个月),pStage II肝转移更早(6.0个月)。

核心结论

  • 结直肠癌根治术后复发风险按pStage、预后因素和转移部位呈现不同时间模式,支持制定风险和时间适配的术后监测策略。

研究设计与样本

  • 回顾性汇总个体参与者数据分析,整合日本临床肿瘤组四项III期随机对照试验,共纳入3655例根治性切除pStage II/III结直肠癌患者(pStage II 816例,pStage III 2839例)。
  • 采用双权重核平滑风险函数估计时间依赖复发风险,峰值时间定义为术后5年内最大风险。

主要发现

  • pStage II和III的5年无复发生存率分别为87.9%和77.0%。
  • pStage II复发风险峰值在10.0个月,pStage III在12.8个月。
  • pStage II中年龄≥70岁和pT4为独立不良预后因素;pStage III中年龄≥70岁、男性、pT4、pN2及未接受辅助化疗与较差RFS独立相关。
  • pStage II中年龄<70岁者复发峰值早于≥70岁者(9.0个月 vs 12.9个月)。
  • pStage III中未接受辅助化疗者复发峰值早于接受者(3.3个月 vs 12.8个月);肝转移复发风险峰值最早(8.0个月),pStage II肝转移为6.0个月。

临床怎么用

  • 术后监测策略可考虑按pStage、预后因素和常见转移部位的时间分布调整随访强度。
  • 对pStage III未接受辅助化疗者及pStage II年轻患者,应关注更早的复发风险高峰。
  • 肝转移风险高峰较早,尤其pStage II患者,监测肝脏时需注意早期时段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative surveillance for colorectal cancer (CRC) remains largely uniform despite potentially time-dependent recurrence hazards. Understanding temporal recurrence dynamics may help refine surveillance strategies. However, data on temporal recurrence patterns in CRC remain limited, particularly across stage, risk, and recurrence sites. METHODS: This retrospective pooled individual participant data analysis integrated four RCTs conducted by the Japan Clinical Oncology Group. A total of 3655 patients with curatively resected pathological stage (pStage) II/III CRC were analysed (816 pStage II; 2839 pStage III). Time-dependent recurrence hazards were estimated using biweight kernel-smoothed hazard functions. Peak timing was defined as the maximum hazard within the first 5 years postoperatively. Analyses were stratified by pStage, prognostic factors identified using multivariable Cox regression, and recurrence site. RESULTS: Five-year relapse-free survival (RFS) was 87.9% in pStage II and 77.0% in pStage III. Peak recurrence hazard was observed at 10.0 and 12.8 months in pStage II and III, respectively. In pStage II, age ≥ 70 years and pT4 were independent poor prognostic factors. In pStage III, age ≥ 70 years, male sex, pT4, pN2 and absence of adjuvant chemotherapy (ACT) were independently associated with poorer RFS. Patients aged < 70 years in pStage II showed earlier peak timing than those aged ≥ 70 years (9.0 versus 12.9 months). In pStage III, patients without ACT showed earlier peak timing than those receiving ACT (3.3 versus 12.8 months). Site-specific analysis showed that liver metastasis had the earliest peak recurrence hazard (8.0 months), particularly in pStage II (6.0 months). CONCLUSIONS: Postoperative recurrence hazards showed distinct temporal patterns according to pStage, prognostic factors, and metastatic sites. These findings suggest that considering not only who is at risk, but also when the risk is highest, supports the development of risk- and time-adapted postoperative surveillance strategies.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Tashiro K, Osumi H, Kataoka K, et al. Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4). Eur J Cancer. 2026. PMID: 42520593. doi:10.1016/j.ejca.2026.116957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。